首頁 > 市場調查報告書 > 製藥

婦科治療

市場調查報告書

商品編碼

1467804

2024-2032 年按藥物類別（促性腺激素、芳香酶抑制劑、選擇性雌激素受體調節劑、雙胍類等）、給藥途徑、配銷通路、最終用戶和地區分類的不孕不育藥物市場報告

Infertility Drugs Market Report by Drug Class (Gonadotropin, Aromatase Inhibitors, Selective Estrogen Receptor Modulators, Biguanides, and Others), Route of Administration, Distribution Channel, End User, and Region 2024-2032

出版日期: 2024年04月08日 | 出版商:

IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

IMARC Group年，全球不孕症藥物市場規模達39億美元。

不孕症藥物是指用於治療不孕症和增強個體生殖健康的各種藥物。它們可以注射或口服。一些常用的不孕藥物包括促性腺激素、芳香酶抑制劑、選擇性雌激素受體調節劑（SERM）、雙胍類、排卵興奮劑、多巴胺激動劑和三環類抗憂鬱劑。它們的作用是刺激女性卵巢的排卵和卵泡發育，而它們則有助於恢復男性睪固酮水平並提高精子品質以實現懷孕。近年來，不孕症藥物在無法懷孕的夫婦中越來越受歡迎。

不孕不孕藥物市場趨勢：

不孕症藥物透過恢復個人受孕的能力來幫助提高夫婦懷孕的機會。因此，不孕症和流產發生率的上升是推動市場成長的主要因素。除此之外，各國政府為提高人們對現有治療方案的認知而採取的幾項有利措施正在刺激對不孕症藥物的需求。此外，由於忙碌的工作日程、隨之而來的壓力和生活方式的改變，癌症、肥胖、糖尿病、甲狀腺、多囊性卵巢症候群（PCOS）和更年期疾病等慢性疾病的盛行率顯著增加。同時，由於延遲懷孕、晚婚以及過度飲酒、吸毒和吸煙等不健康習慣導致的生育率下降，正在加速產品的採用率。此外，一些主要參與者正在從事研發（R＆D）活動，以推出具有更高功效、更低劑量要求和更少副作用的創新不孕症藥物。此外，用於開發這些藥物的公共資金的增加以及各個監管機構更快的藥物批准正在推動市場的成長。其他因素，包括對學名藥的需求不斷增加、醫療保健基礎設施改善、消費者支出能力不斷提高、快速城市化和技術進步，也為市場成長提供了積極的推動力。

本報告回答的關鍵問題：

迄今為止，全球不孕症藥物市場表現如何，未來幾年將如何表現？
COVID-19 對全球不孕症藥物市場有何影響？
主要區域市場有哪些？
根據藥物類別分類的市場是怎麼樣的？
根據給藥途徑，市場的分化為何？
基於配銷通路的市場區隔是什麼？
基於最終用戶的市場區隔是什麼？
產業價值鏈的各個階段是什麼？
該行業的關鍵促進因素和挑戰是什麼？
全球不孕症藥物市場的結構如何？
產業競爭程度如何？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 11 章：SWOT 分析

概述
優勢
弱點
機會
威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abbott Laboratories
- Bayer AG
- Ferring Pharmaceuticals
- Livzon Pharmaceutical Group Inc.
- Mankind Pharma
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Theramex

簡介目錄圖表

Product Code: SR112024A5239

The global infertility drugs market size reached US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032.

Infertility drugs refer to various medications used to treat infertility and enhance the reproductive health of an individual. They are either injected or taken orally. Some commonly used infertility drugs include gonadotrophins, aromatase inhibitors, selective estrogen receptor modulators (SERMs), biguanides, ovulatory stimulants, dopamine agonists, and tricyclic antidepressants. They work by stimulating ovulation and follicle development of the ovary in women, whereas they help restore testosterone levels and improve the quality of sperm in men to bring about pregnancy. In recent years, infertility drugs have gained traction among couples who are unable to conceive.

Infertility Drugs Market Trends:

Infertility drugs assist in enhancing the chances of pregnancy in couples by restoring the ability of an individual to contribute to conception. As a result, the rising incidences of infertility and miscarriage represents the primary factor driving the market growth. Besides this, several favorable initiatives undertaken by governments of various countries to spread awareness regarding the available treatment options are catalyzing the demand for infertility drugs. Additionally, there has been a significant increase in the prevalence of chronic diseases, such as cancer, obesity, diabetes, thyroid, polycystic ovarian syndrome (PCOS), and menopausal disorders, on account of hectic work schedules, accompanying stress, and lifestyle changes. Along with this, the declining fertility rates due to delayed pregnancies, late marriages, and unhealthy habits, such as excessive consumption of alcohol, drugs, and smoking, are accelerating the product adoption rates. Furthermore, several key players are engaging in research and development (R&D) activities to launch innovative infertility drugs with enhanced efficacy, lower dosage requirements, and fewer side effects. Moreover, the increasing public funding for developing these drugs and faster drug approvals from various regulatory bodies are propelling the market growth. Other factors, including the escalating demand for generic medicines, improving healthcare infrastructure, rising consumer expenditure capacities, rapid urbanization, and technological advancements, are also providing a positive thrust to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global infertility drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class, route of administration, distribution channel and end user.

Breakup by Drug Class:

Gonadotropin

Aromatase Inhibitors

Selective Estrogen Receptor Modulators (SERMs)

Biguanides

Others

Breakup by Route of Administration:

Oral

Intravenous

Subcutaneous

Intramuscular

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Others

Breakup by End User:

Male

Female

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Bayer AG, Ferring Pharmaceuticals, Livzon Pharmaceutical Group Inc., Mankind Pharma, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Theramex.

Key Questions Answered in This Report:

How has the global infertility drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global infertility drugs market?
What are the key regional markets?
What is the breakup of the market based on the drug class?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global infertility drugs market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Infertility Drugs Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Class

6.1 Gonadotropin
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Aromatase Inhibitors
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Selective Estrogen Receptor Modulators (SERMs)
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Biguanides
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

7.1 Oral
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Intravenous
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Subcutaneous
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Intramuscular
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

8.1 Hospital Pharmacies
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Retail Pharmacies
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Others
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by End User

9.1 Male
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Female
- 9.2.1 Market Trends
- 9.2.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
- 15.3.2 Bayer AG
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Ferring Pharmaceuticals
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Livzon Pharmaceutical Group Inc.
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 Mankind Pharma
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Merck & Co. Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 Merck KGaA
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Novartis AG
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Pfizer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
- 15.3.10 Sanofi S.A.
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis
- 15.3.11 Theramex
  - 15.3.11.1 Company Overview
  - 15.3.11.2 Product Portfolio

簡介目錄圖表

List of Figures

Figure 1: Global: Infertility Drugs Market: Major Drivers and Challenges
Figure 2: Global: Infertility Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Infertility Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Infertility Drugs Market: Breakup by Drug Class (in %), 2023
Figure 5: Global: Infertility Drugs Market: Breakup by Route of Administration (in %), 2023
Figure 6: Global: Infertility Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Infertility Drugs Market: Breakup by End User (in %), 2023
Figure 8: Global: Infertility Drugs Market: Breakup by Region (in %), 2023
Figure 9: Global: Infertility Drugs (Gonadotropin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Infertility Drugs (Gonadotropin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Infertility Drugs (Aromatase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Infertility Drugs (Aromatase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Infertility Drugs (Selective Estrogen Receptor Modulators (SERMs)) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Infertility Drugs (Biguanides) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Infertility Drugs (Biguanides) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Infertility Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Infertility Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Infertility Drugs (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Infertility Drugs (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Infertility Drugs (Intravenous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Infertility Drugs (Intravenous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Infertility Drugs (Subcutaneous) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Infertility Drugs (Subcutaneous) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Infertility Drugs (Intramuscular) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Infertility Drugs (Intramuscular) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Infertility Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Infertility Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Infertility Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Infertility Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Infertility Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Infertility Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Infertility Drugs (Male) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Infertility Drugs (Male) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Infertility Drugs (Female) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Infertility Drugs (Female) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Infertility Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Infertility Drugs Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Infertility Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Infertility Drugs Industry: SWOT Analysis
Figure 87: Global: Infertility Drugs Industry: Value Chain Analysis
Figure 88: Global: Infertility Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infertility Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Infertility Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2024-2032
Table 3: Global: Infertility Drugs Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 4: Global: Infertility Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Infertility Drugs Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: Infertility Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Infertility Drugs Market: Competitive Structure
Table 8: Global: Infertility Drugs Market: Key Players

02-2729-4219

+886-2-2729-4219